Tag:

Haemophilus influenzae B

Latest Headlines

Latest Headlines

Takeda's Hib vaccine gets Japanese approval

January 26, 2016 | By
Almost 7 years after licensing it from Novartis, Takeda picked up a regulatory green light from Japan's Ministry of Health, Labour and Welfare for its Haemophilus influenzae type B (Hib) vaccine. The vaccine, Vaxem Hib, is approved for use in children aged two months to under 5 years.

Early shots do not cause celiac disease

June 28, 2012 | By
In Sweden, between 1984 and 1996, there was a four-fold increase in cases of celiac disease, and the rates then fell as quickly as they rose. A team of Swedish researchers looked at medical records to unpack whether there really was a cause and effect between changes in the vaccination patterns and the spike in disease.

Sanofi's Hexaxim vax gets EMA thumbs up

June 28, 2012 | By
The European Medicines Agency (EMA) has adopted a positive opinion for Sanofi Pasteur's hexavalent vaccine for babies and toddlers, Hexaxim, as part of a procedure designed to evaluate medicinal products intended for markets outside the European Union.

GSK's Nimenrix gets green light in Europe

May 3, 2012 | By
GlaxoSmithKline's meningitis vaccine Nimenrix has been granted approval in Europe by the Committee for Medicinal Products for Human Use (CHMP).
Related Tags
Press Releases
  • St. Jude Medical Receives FDA Approval for Industry's First MultiPoint Pacing Technology
  • Researchers present inner workings of Ebola vaccine trial
  • Durvalumab granted Breakthrough Therapy designation by US FDA for treatment of patients with PD-L1 positive urothelial bladder cancer
  • U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational medicine ocrelizumab in primary progressive multiple sclerosis
  • Protein Sciences and UNIGEN Reach Agreement to Source Flublok® Influenza Vaccine from Japan
  • More Press Releases
Sponsored Links